← Back to headlines
Ozempic Is About to Go Generic in India, China and Canada
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
19 Mar, 04:00 — 19 Mar, 04:00
Related Stories
Νέα έρευνα: Τι βρέθηκε στα ακουστικά που φοράμε για ώρες κάθε μέρα
12m ago
Fire at Bălăceanca Psychiatric Hospital. Dozens of people evacuated
15m ago
Valstybės kontrolė: dalis ministerijų neturi lėšų, kad padėtų vyresniems žmonėms
18m ago
Рискът от епидемия от менингит в Европа се смята за "много нисък"
20m ago